C07D 235/24
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
C07D235/24 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 1,544 US grants and 1,260 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,544
- Published applications
- 1,260
- Assignees
- 751
- Inventors
- 4,791
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 35 | 0 |
| 1977 | 26 | 0 |
| 1978 | 33 | 0 |
| 1979 | 30 | 0 |
| 1980 | 25 | 0 |
| 1981 | 36 | 0 |
| 1982 | 22 | 0 |
| 1983 | 16 | 0 |
| 1984 | 19 | 0 |
| 1985 | 21 | 0 |
| 1986 | 16 | 0 |
| 1987 | 14 | 0 |
| 1988 | 11 | 0 |
| 1989 | 18 | 0 |
| 1990 | 25 | 0 |
| 1991 | 28 | 0 |
| 1992 | 22 | 0 |
| 1993 | 21 | 0 |
| 1994 | 26 | 0 |
| 1995 | 24 | 0 |
| 1996 | 24 | 0 |
| 1997 | 32 | 0 |
| 1998 | 34 | 0 |
| 1999 | 38 | 0 |
| 2000 | 35 | 0 |
| 2001 | 43 | 8 |
| 2002 | 47 | 58 |
| 2003 | 38 | 59 |
| 2004 | 31 | 67 |
| 2005 | 25 | 66 |
| 2006 | 39 | 53 |
| 2007 | 38 | 61 |
| 2008 | 33 | 50 |
| 2009 | 35 | 57 |
| 2010 | 33 | 59 |
| 2011 | 35 | 52 |
| 2012 | 36 | 54 |
| 2013 | 42 | 48 |
| 2014 | 47 | 53 |
| 2015 | 55 | 47 |
| 2016 | 26 | 54 |
| 2017 | 37 | 46 |
| 2018 | 29 | 53 |
| 2019 | 51 | 46 |
| 2020 | 41 | 55 |
| 2021 | 36 | 38 |
| 2022 | 30 | 36 |
| 2023 | 24 | 43 |
| 2024 | 25 | 43 |
| 2025 | 24 | 29 |
| 2026 | 13 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Small molecule inhibitors of SLC15A4 with anti-inflammatory activity1 Sep 2026US 12,723,039 B2The Scripps Research Institute
- N-(benzoyl)-phenylalanine compound, pharmaceutical composition containing same, and use thereof30 Jun 2026US 12,668,575 B2Apeloa Pharmaceutical Co., Ltd.
- Difluorocyclohexyl derivatives as IL-17 modulators23 Jun 2026US 12,662,475 B2Ucb Biopharma Srl
- Benzimidazolone-based cinnamamide derivative as TRPV1 antagonist and pharmaceutical composition for treatment or prevention of pain containing same as active ingredient16 Jun 2026US 12,653,814 B2Jmackem Co., Ltd
- Bicyclic inhibitors of cbx chromodomains8 Oct 2026US 2026/0308130 A1Icahn School of Medicine at Mount Sinai
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Compounds for restoring susceptibility to beta-lactam antibiotics24 Sep 2026US 2026/0284011 A1University of Notre Dame du Lac
- Diamidine analogs for anti-inflammatory use10 Sep 2026US 2026/0263426 A1Montdorex Inc.
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
Most cited
By later US patents
- Heterocyclic compounds useful as inhibitors of tyrosine kinases202US 6,506,769 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2003
- Heterocyclic compounds useful as inhibitors of tyrosine kinases190US 6,770,639 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2004
- Benzimidazoles useful as angiotensin-11 antagonists142US 5,591,762 ADr. Karl Thomae GmbH · 1997
- Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic compounds having neuroleptic activity127US 4,831,031 APfizer Inc. · 1989
- Compounds enhancing antitumor activity of other cytotoxic agents116US 6,130,217 APfizer Inc. · 2000